Company / Income Tax
NOVAVAX INC Income Tax History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$1.9M
FY2025
5-year range
$0 / $29.2M
FY2021-FY2025
Trend
-82.9%
vs FY2024
Sector context
#66 of 204
Health Care
What the data says
At $2M, NOVAVAX INC's income tax ranks #139 of 204 in the Health Care sector. Income Tax has fluctuated over the past 6 years, ranging from $0 in FY2022 to $29M in FY2021.
Based on SEC 10-K filings.
$2M in FY2025.
Improved from $2M to $2M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#139 of 204 in Health CareTop 68% of 204This company $1.9M Sector average $118.7M
▼
-98.4% below sector average
Key checks
Key Insights
- In FY2025, income tax decreased 82.9% year-over-year.
- Ranks #66 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2021.
- Lowest income tax in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.9M | -82.9% |
| FY2024 | $10.9M | +435.9% |
| FY2023 | $2.0M | - |
| FY2022 | $0 | -100.0% |
| FY2021 | $29.2M | - |
| FY2020 | $0 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026